These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37354827)

  • 1. NOX2 inhibition stabilizes vulnerable plaques by enhancing macrophage efferocytosis via MertK/PI3K/AKT pathway.
    Wang Y; Liu XY; Wang Y; Zhao WX; Li FD; Guo PR; Fan Q; Wu XF
    Redox Biol; 2023 Aug; 64():102763. PubMed ID: 37354827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis.
    Che X; Xiao Q; Song W; Zhang H; Sun B; Geng N; Tao Z; Shao Q; Pu J
    J Am Heart Assoc; 2021 May; 10(10):e018455. PubMed ID: 33969692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
    Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner.
    Ding S; Lin N; Sheng X; Zhao Y; Su Y; Xu L; Tong R; Yan Y; Fu Y; He J; Gao Y; Yuan A; Ye L; Reiter RJ; Pu J
    J Pineal Res; 2019 Sep; 67(2):e12581. PubMed ID: 31009101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
    Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
    J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
    Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
    J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.
    Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z
    Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649
    [No Abstract]   [Full Text] [Related]  

  • 10. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HuoXueTongFu formula induces M2c macrophages via the MerTK/PI3K/AKT pathway to eliminate NETs in intraperitoneal adhesion in mice.
    Zhao M; Chen Y; Bao X; Wang Z; Yuan N; Jin Z; Huang Y; Yang L; Yang Y; Zeng L
    J Ethnopharmacol; 2024 Sep; 331():118290. PubMed ID: 38703872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
    Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
    Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
    She Y; Xu X; Yu Q; Yang X; He J; Tang XX
    Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
    Kayashima Y; Makhanova N; Maeda N
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque.
    Zhai C; Cheng J; Mujahid H; Wang H; Kong J; Yin Y; Li J; Zhang Y; Ji X; Chen W
    PLoS One; 2014; 9(3):e90563. PubMed ID: 24599185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-80003 Inhibition of Macrophage Apoptosis and Necrotic Core Development in Atherosclerotic Vulnerable Plaques.
    Wang X; Sun Z; Yuan R; Zhang W; Shen Y; Yin A; Li Y; Ji Q; Wang X; Li Y; Zhang M; Pan X; Shen L; He B
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1061-1073. PubMed ID: 34410548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PM
    Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
    Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.